Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Who Should Avoid Peptide Therapy The following patient profiles are not appropriate candidates for peptide therapy, based on contraindication guidance from Bonza Health and Stem Cell MIA: Current or recent cancer diagnosis: Peptides that elevate IGF-1 or activate angiogenesis pathways present an unacceptable theoretical risk in individuals with active or recently treated malignancy
You should avoid IV or compounded glutathione without medical supervision due to reported safety risks
R., Salehi, M., & Jabari, A
[2] International Journal of Dermatology , August 2021, pages 1013-1018 [3] Arjinpathana N, Asawanonda P
260 Studies in animal models of PCOS suggest DHEA treatment may contribute to poor ovarian health and function in the context of this condition
